You can buy or sell VNDA and other stocks, options, ETFs, and crypto commission-free!
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Read More Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Washington, District of Columbia
52 Week High
52 Week Low
Yahoo FinanceMar 14
CLASS ACTION UPDATE for MU, STMP and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / March 14, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.
Yahoo FinanceMar 11
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MKL, VNDA and CTL
NEW YORK, NY / ACCESSWIRE / March 11, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies.
Guru FocusMar 7
Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Vanda Pharmaceuticals Inc.
Expected May 1, After Hours